Recent advances in our understanding of the pathophysiology of asthma have led to improved control, particularly for those patients with moderate-to-severe disease who remain uncontrolled after receiving traditional asthma therapies. Keeping pace with these guidelines and emerging data from major conferences can quickly become overwhelming, so to help healthcare professionals stay up to date, this expert discussion reviews key data presented at CHEST 2019.